Sectoral Asset Management Inc Glycomimetics Inc Transaction History

Sectoral Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.8 - $12.85 $1.55 Million - $7.1 Million	-552,806 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.6 - $13.12 $50,869 - $62,962	4,799 Added 0.88%	552,806 $6.59 Million
Q1 2019 May 14, 2019	BUY	$9.96 - $13.44 $5.46 Million - $7.37 Million	548,007 New	548,007 $6.83 Million

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.